Skip to NavigationSkip to content

News

Just in time for the Christmas period, the final Pharmafocus issue of the year and the Autumn 2017 edition of Pharmafile, our bi-annual market...
ISoP, alongside Primevigilance, is offering a unique, highly focused, scientific and interactive two-day seminar that will explore the emerging tools...
Regeneron had been looking to pair Eylea with nesvacumab but this appears to be a no-go, after the biotech stated that the results of two trials were...
The Veeva European Commercial & Medical Summit will begin tomorrow, seeing more than 800 industry leaders convene at the Marriot Auditorium Hotel...
Bayer has been hit by the news that its latest effort in the pneumonia space, Amikacin Inhale, has failed at the Phase 3 stage.
After successes in the Chinese market was noted in Q3 filings, it should be no surprise that AZ has announced further plans to cement its position in...
President Donald Trump’s budget proposes to cut funding to the National Institutes of Health by $7.2 billion or 21%. Researchers at the Washington...
With Brexit negotiations progressing at a snail’s pace, the government needed a boost to show that its economic plans were proving fruitful and they...
Amsterdam snatches up the EMA in a tie-break draw, Teva announces colossal staff cuts, and Europe gets its first Herception biosimilar approval....
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches